Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors ; volume:18 ; number:1 ; day:24 ; month:4 ; year:2018 ; pages:1-12 ; date:12.2018
Cancer cell international ; 18, Heft 1 (24.4.2018), 1-12, 12.2018
- Urheber
-
Aveic, Sanja
- Beteiligte Personen und Organisationen
-
Pantile, Marcella
Polo, Pierfrancesco
Sidarovich, Viktoryia
Mariano, Marilena De
Quattrone, Alessandro
Longo, Luca
Tonini, Gian Paolo
SpringerLink (Online service)
- DOI
-
10.1186/s12935-018-0557-4
- URN
-
urn:nbn:de:101:1-2018062823181425450732
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aveic, Sanja
- Pantile, Marcella
- Polo, Pierfrancesco
- Sidarovich, Viktoryia
- Mariano, Marilena De
- Quattrone, Alessandro
- Longo, Luca
- Tonini, Gian Paolo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity
A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor
Editorial: Targeting bruton tyrosine kinase
Ibrutinib, a Bruton’s tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
Newer Tyrosine Kinase Inhibitors for CML
Harnessing autophagy to potentiate the antitumor effects of the tyrosine kinase inhibitor cabozantinib in prostate cancer cells
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation
Second-generation inhibitors of Bruton tyrosine kinase
Targeting tumour microenvironment by tyrosine kinase inhibitor
Bcr-Abl tyrosine kinase inhibitors- current status
Auto-thiophosphorylation activity of Src tyrosine kinase
Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity
A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor
Editorial: Targeting bruton tyrosine kinase
Ibrutinib, a Bruton’s tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
Newer Tyrosine Kinase Inhibitors for CML
Harnessing autophagy to potentiate the antitumor effects of the tyrosine kinase inhibitor cabozantinib in prostate cancer cells
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation
Second-generation inhibitors of Bruton tyrosine kinase
Targeting tumour microenvironment by tyrosine kinase inhibitor
Bcr-Abl tyrosine kinase inhibitors- current status
Auto-thiophosphorylation activity of Src tyrosine kinase
Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity
A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor
Editorial: Targeting bruton tyrosine kinase
Ibrutinib, a Bruton’s tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
Newer Tyrosine Kinase Inhibitors for CML
Harnessing autophagy to potentiate the antitumor effects of the tyrosine kinase inhibitor cabozantinib in prostate cancer cells
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation
Second-generation inhibitors of Bruton tyrosine kinase
Targeting tumour microenvironment by tyrosine kinase inhibitor
Bcr-Abl tyrosine kinase inhibitors- current status